What is the typical dosing regimen for Amoxiclav (amoxicillin-clavulanate) for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxiclav (Amoxicillin-Clavulanate) Dosing Regimens for Bacterial Infections

For adults with bacterial infections, the standard dosing regimen for amoxicillin-clavulanate is 875/125 mg twice daily or 500/125 mg three times daily, with the twice-daily regimen preferred due to better tolerability and similar efficacy. 1

Adult Dosing

Standard Dosing Options

  • 875/125 mg twice daily (every 12 hours) - preferred regimen for most infections 1

    • Recommended for severe infections and respiratory tract infections 1
    • Associated with lower incidence of diarrhea compared to three-times-daily dosing (15% vs 14% for severe diarrhea) 1
  • 500/125 mg three times daily (every 8 hours) - alternative regimen 1

    • Similar clinical efficacy to twice-daily dosing but higher incidence of diarrhea 1

Specific Infection Types

  • Skin and soft tissue infections: 875/125 mg twice daily 2
  • Animal or human bites: 875/125 mg twice daily 2
  • Respiratory tract infections: 875/125 mg twice daily 1
  • Complicated urinary tract infections: 875/125 mg twice daily 1

Special Populations

  • Renal impairment: Patients with glomerular filtration rate <30 mL/min should not receive the 875 mg dose 1

Pediatric Dosing

Standard Dosing Options

  • 45 mg/kg/day of amoxicillin component in 2 divided doses (twice daily) 1

    • Preferred regimen with lower incidence of diarrhea (14% vs 34%) 1
  • 40 mg/kg/day of amoxicillin component in 3 divided doses (three times daily) 1

Age-Based Dosing for Co-amoxiclav

  • <1 year: 2.5 mL/kg of 125/31 suspension three times daily 2
  • 1-6 years: 5 mL of 125/31 suspension three times daily 2
  • >6 years: 5 mL of 250/62 suspension three times daily 2

Administration Guidelines

  • Take at the start of a meal to minimize gastrointestinal intolerance 1
  • Enhanced absorption of clavulanate when taken with food 1
  • Duration of therapy typically 7-10 days for most infections 2

Pharmacokinetic Considerations

  • The twice-daily regimen (875/125 mg) provides comparable tissue concentrations to the three-times-daily regimen (500/125 mg) 3
  • Time above MIC (T>MIC) is a critical pharmacodynamic parameter for amoxicillin efficacy 4
  • For optimal efficacy, dosing interval should maintain plasma concentrations above the MIC for at least 40-50% of the dosing interval 4

Common Adverse Effects

  • Diarrhea: Most common adverse effect (14-15%) 1
    • Lower incidence with twice-daily dosing compared to three-times-daily dosing 1
    • Severe diarrhea or withdrawal due to diarrhea: 1% for twice-daily vs 2% for three-times-daily regimen 1

Clinical Pearls

  • High-dose amoxicillin-clavulanate (additional 875 mg amoxicillin) has not shown superior efficacy compared to standard-dose for acute sinusitis in adults 5
  • Pharmacokinetically enhanced formulations (2000/125 mg) have been developed to maintain therapeutic plasma concentrations for longer periods, potentially improving efficacy against resistant pathogens 6
  • The clavulanate component is limited to 125 mg per dose in adult formulations due to tolerability issues 7

Cautions

  • Overuse may select for extended-spectrum beta-lactamase (ESBL)-producing organisms 7
  • Susceptibility testing methods and interpretive criteria differ between CLSI and EUCAST 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.